These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23830275)

  • 1. [Sexual side effects of pharmacological treatments].
    Giuliano F; Droupy S
    Prog Urol; 2013 Jul; 23(9):804-10. PubMed ID: 23830275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs.
    La Torre A; Giupponi G; Duffy D; Conca A; Cai T; Scardigli A
    Pharmacopsychiatry; 2016 Jan; 49(1):3-13. PubMed ID: 26569417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC
    BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
    Seftel A; Rosen R; Kuritzky L
    Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
    Rosen RC; Giuliano F; Carson CC
    Eur Urol; 2005 Jun; 47(6):824-37. PubMed ID: 15925080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
    Rosen RC
    Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.
    Mirone V; Sessa A; Giuliano F; Berges R; Kirby M; Moncada I
    Int J Clin Pract; 2011 Sep; 65(9):1005-13. PubMed ID: 21718399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.
    Capitanio U; Salonia A; Briganti A; Montorsi F
    Int J Clin Pract; 2013 Jun; 67(6):544-51. PubMed ID: 23409749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced sexual dysfunction.
    Aldridge SA
    Clin Pharm; 1982; 1(2):141-7. PubMed ID: 6764386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.
    Rosen RC; Wei JT; Althof SE; Seftel AD; Miner M; Perelman MA;
    Urology; 2009 Mar; 73(3):562-6. PubMed ID: 19167031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Questionnaires in sexual medicine].
    Giuliano F
    Prog Urol; 2013 Jul; 23(9):811-21. PubMed ID: 23830276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sexuality of men with neurologic disorders].
    Denys P; Soler JM; Giuliano F
    Prog Urol; 2013 Jul; 23(9):712-7. PubMed ID: 23830265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.
    Gur S; Kadowitz PJ; Hellstrom WJ
    Expert Opin Drug Saf; 2013 Jan; 12(1):81-90. PubMed ID: 23173718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of medical treatments for benign prostatic hyperplasia on sexual function.
    Giuliano F
    BJU Int; 2006 Apr; 97 Suppl 2():34-8; discussion 44-5. PubMed ID: 16507052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant drug therapy and sexual dysfunction in men: a review.
    Mitchell JE; Popkin MK
    J Clin Psychopharmacol; 1983 Apr; 3(2):76-9. PubMed ID: 6341418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs.
    La Torre A; Giupponi G; Duffy D; Conca A; Catanzariti D
    Pharmacopsychiatry; 2015 Jan; 48(1):1-6. PubMed ID: 25405774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].
    Rosen R; Altwein J; Boyle P; Kirby RS; Lukacs B; Meuleman E; O'Leary MP; Puppo P; Chris R; Giuliano F
    Prog Urol; 2004 Jun; 14(3):332-44. PubMed ID: 15373175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Carson CC
    BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.